$3.22 Billion is the total value of QVT Financial LP's 77 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AXGT | AXOVANT SCIENCES LTD | $1,120,500,000 | +20.3% | 75,000,000 | 0.0% | 34.80% | +23.0% | |
| MYOV | MYOVANT SCIENCES LTD | $437,096,000 | -5.6% | 37,231,342 | 0.0% | 13.58% | -3.5% | |
| TAL ED GROUPnote 2.500% 5/1 | $117,703,000 | +51.5% | 29,000,000 | 0.0% | 3.66% | +54.9% | ||
| ABUS | ARBUTUS BIOPHARMA CORP | $52,044,000 | +32.7% | 16,013,540 | 0.0% | 1.62% | +35.6% | |
| SHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0 | $43,486,000 | -0.8% | 39,986,000 | 0.0% | 1.35% | +1.5% | ||
| ANTHEM INCnote 2.750%10/1 | $37,914,000 | +15.0% | 16,500,000 | 0.0% | 1.18% | +17.5% | ||
| CTRIP COM INTL LTDnote 1.250%10/1 | $32,323,000 | +13.8% | 24,500,000 | 0.0% | 1.00% | +16.3% | ||
| ATEX | PDVWIRELESS INC | $16,931,000 | -5.9% | 894,031 | 0.0% | 0.53% | -3.8% | |
| CTRIP COM INTL LTDnote 1.000% 7/0 | $14,066,000 | +8.2% | 12,650,000 | 0.0% | 0.44% | +10.6% | ||
| HD | HOME DEPOT INC | $11,306,000 | +9.5% | 77,000 | 0.0% | 0.35% | +11.8% | |
| HNTUF | HUNTER MARITIME ACQUISITIONunit 99/99/9999 | $10,400,000 | +2.5% | 1,000,000 | 0.0% | 0.32% | +4.9% | |
| JPM | JPMORGAN CHASE & CO | $9,661,000 | +1.8% | 109,985 | 0.0% | 0.30% | +4.2% | |
| AR | ANTERO RES CORP | $8,518,000 | -3.5% | 373,413 | 0.0% | 0.26% | -1.1% | |
| WFC | WELLS FARGO & CO NEW | $7,888,000 | +1.0% | 141,712 | 0.0% | 0.24% | +3.4% | |
| BGNE | BEIGENE LTDsponsored adr | $6,224,000 | +20.6% | 170,000 | 0.0% | 0.19% | +22.9% | |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | $4,729,000 | +19.4% | 2,556,256 | 0.0% | 0.15% | +22.5% | |
| BIIB | BIOGEN INC | $3,215,000 | -3.6% | 11,760 | 0.0% | 0.10% | -1.0% | |
| INSW | INTERNATIONAL SEAWAYS INC | $350,000 | +36.2% | 18,309 | 0.0% | 0.01% | +37.5% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.